Biomarker HF Risk Score in Diabetes Seen as SGLT2i Lodestar Biomarker HF Risk Score in Diabetes Seen as SGLT2i Lodestar
Together, 4 ' easily measured ' biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying best candidates for SGLT2 inhibitor therapy, some say.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news